Neoadjuvant or Adjuvant Therapy for Resectable Gastric Cancerenglish
Adult patients with potentially curable, surgically resectable (Stage 1B [invasion of the muscularis propria] and above) gastric cancer.
Intended Guideline Users
Clinicians and healthcare providers involved in the management and referral of patients with resectable gastric cancer.
Should patients with resectable gastric cancer (Stage 1B [invasion of the muscularis propria] and above) receive neoadjuvant or adjuvant therapy in addition to surgery? Outcomes of interest are overall survival (OS), disease-free survival (DFS), and adverse events.